Eric N. Brown

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy”.

SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0361

N/A

0.639DataRank · unranked

70 citations

Manish R. Sharma, Melissa L. Johnson, Timothy A. Yap, Shirish M. Gadgeel, Dale Nepert +20 more

MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2208900119

N/A

0DataRank · unranked

38 citations

Nicholas J. Rettko, Owen Leddy, Joshua M. Mesfin, Eric N. Brown, Shannon L. Winski +4 more

MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.10.475285

N/A

0DataRank · unranked

2 citations

Nicholas J. Rettko, Owen Leddy, Joshua M. Mesfin, Eric N. Brown, Shannon L. Winski +4 more

Data from SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy

(2023)10.1158/2159-8290.c.6679570

N/A

0DataRank · unranked

0 citations

Manish R. Sharma, Melissa L. Johnson, Timothy A. Yap, Shirish M. Gadgeel, Dale Nepert +20 more